RIGL
Rigel Pharmaceuticals
3월 13일 4:00 PM ET (한국 3/14 05:00)
$25.95
-0.65 ▼ -2.44%
🌙 3월 13일 7:22 PM ET (한국 3/14 08:22)
$26.16
+0.21 ▲ +0.81%
| Index | RUT | P/E | 1.37 | EPS (ttm) | 18.91 | Insider Own | 3.15% | Shs Outstand | 0.02B | Perf Week | -10.11% |
| Market Cap | 0.48B | Forward P/E | 6.23 | EPS next Y | -4.09% | Insider Trans | -0.68% | Shs Float | 0.02B | Perf Month | -25.73% |
| Enterprise Value | 0.38B | PEG | - | EPS next Q | 0.84 | Inst Own | 87.85% | Short Float | 20.98% | Perf Quarter | -37.05% |
| Income | 0.37B | P/S | 1.63 | EPS this Y | -77.69% | Inst Trans | 6.55% | Short Ratio | 8.6 | Perf Half Y | -31.39% |
| Sales | 0.29B | P/B | 1.21 | EPS next 5Y | - | ROA | 69.66% | Short Interest | 3.75M | Perf YTD | -39.41% |
| Book/sh | 21.38 | P/C | 3.09 | EPS past 3/5Y | - | ROE | 185.94% | 52W High | -50.33% ($52.24) | Perf Year | 30.34% |
| Cash/sh | 8.39 | P/FCF | 6.34 | Sales past 3/5Y | 34.76% 22.06% | ROIC | 88.58% | 52W Low | 67.42% ($15.50) | Perf 3Y | 64.24% |
| Dividend Est. | - | EV/EBITDA | 2.95 | EPS Y/Y TTM | 1947.02% | Gross Margin | 93.33% | Volatility(W/M) | 5.22% 5.14% | Perf 5Y | -38.65% |
| Dividend TTM | - | EV/Sales | 1.28 | Sales Y/Y TTM | 64.15% | Oper. Margin | 42.63% | ATR (14) | 1.76 | Perf 10Y | 10.9% |
| Dividend Ex-Date | - | Quick Ratio | 2.3 | EPS Q/Q | 1598.57% | Profit Margin | 124.72% | RSI (14) | 22.28 | Recom | 1.8 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.42 | Sales Q/Q | 21.19% | SMA20 | -19.35% ($32.18) | Beta | 1.25 | Target Price | $51.2 |
| Payout | - | Debt/Eq | 0.14 | Earnings | 3000000 | SMA50 | -27.04% ($35.57) | Rel Volume | 0.95 | Prev Close | $26.6 |
| Employees | 174 | LT Debt/Eq | 0.06 | EPS/Sales Surpr. | 1026.92% 1.6% | SMA200 | -20.42% ($32.61) | Avg Volume(3M) | 0.44M | Price | $25.95 |
| IPO | 2000/11/29 | Option/Short | Yes/Yes | Trades | 5586 | Volume | 415,910 | Change | -2.44% |
뉴스 로딩 중...